Protalix Biotherapeutics Inc (NYSE American:PLX)

0.45
Delayed Data
As of Apr 18
 0.00 / 0.00%
Today’s Change
0.42
Today|||52-Week Range
1.09
-31.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues15.2M4.4M9.2M19.2M
 
 
 
 
 
Cost of Goods Sold5.9M730.0K6.4M13.3M
 
 
 
 
 
Depreciation And Amortization3.1M2.4M2.0M1.9M
 
 
 
 
 
 
Operating ExpensesGross Income6.1M1.3M801.0K4.0M
 
 
 
 
 
General Expenses38.4M29.8M39.8M43.7M
 
 
 
 
 
Research And Development29.8M24.9M30.4M32.2M
 
 
 
 
 
Total Operating Expenses47.5M32.9M48.2M58.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-32.3M-28.5M-39.0M-39.7M
 
 
 
 
 
Extraordinary Credit--0.0014.1M0.00
 
 
Extraordinary Charge-1.0M0.000.00-39.4M
 
 
 
Interest Expense On Debt4.9M3.7M10.7M9.7M
 
 
 
 
 
Other Expenses8.1M4.9M5.8M3.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-29.9M-27.3M-29.2M-85.3M
 
 
 
 
 
Discontinued Operations0.0045.4M-189.0K0.00
 
 
 
Extraordinary Items0.0039.9M0.000.00
 
 
Net Income-29.9M18.1M-29.4M-85.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS92.9M94.9M101.4M131.1M
 
 
 
 
 
Shares To Calculate EPS Diluted92.9M94.9M101.4M131.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.32$0.61-$0.29-$0.65
 
 
 
 
 
EPS Diluted-$0.32$0.19-$0.29-$0.65